The Gene Regulation (GR) Program Area was founded in 1999, with the goal of encouraging a strong group of UCLA researchers pursuing fundamental mechanisms of gene regulation to initiate and expand studies relevant to cancer. The Program Area's current goals are to study basic mechanisms of gene regulation in normal somatic cells, stem cells, and cancer cells, to provide sophisticated knowledge of gene regulation concepts and methodology to researchers in other JCCC program areas, and to facilitate the transition of basic gene regulation discoveries into clinical applications. We have encouraged our members to focus on cancer through activities that promote the intra- and inter-programmatic exchange of ideas, by recruiting new investigators, by providing seed funds for cancer-relevant projects, and by developing experimental methods to enable state-of-the-art studies in gene regulation. Fifteen years after the GR Program Area was established, our initial expectations have been met and exceeded. Several researchers who previously focused on fundamental mechanisms of gene regulation are now also actively pursuing studies with direct cancer relevance, including translational research.
One aim i s to leverage our current pre-translational studies into direct clinical applications. Other ongoing efforts are aimed at increasing avenues for interaction with members from other JCCC program areas. The Gene Regulation Program Area is comprised of 25 members, including four

Public Health Relevance

Changes in gene expression caused by the aberrant activation of oncogenes and aberrant inactivation of tumor suppressor genes represent a fundamental property of cancer cells. Cancer cells aberrantly express, or fail to express, genes involved in growth and cell cycle control, as well as genes involved in differentiation and other physiological processes. An improved understanding of the fundamental mechanisms of gene regulation, and of the mechanisms responsible for the growth and survival of cancer cells, is likely to lead to novel therapeutic and diagnostic strategies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016042-39
Application #
8635430
Study Section
Subcommittee G - Education (NCI)
Project Start
1996-12-01
Project End
2018-11-30
Budget Start
2014-03-07
Budget End
2014-11-30
Support Year
39
Fiscal Year
2014
Total Cost
$29,265
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Leoh, Lai Sum; Kim, Yoon Kyung; Candelaria, Pierre V et al. (2018) Efficacy and Mechanism of Antitumor Activity of an Antibody Targeting Transferrin Receptor 1 in Mouse Models of Human Multiple Myeloma. J Immunol 200:3485-3494
Hicks, Michael R; Hiserodt, Julia; Paras, Katrina et al. (2018) ERBB3 and NGFR mark a distinct skeletal muscle progenitor cell in human development and hPSCs. Nat Cell Biol 20:46-57
Tsang, Eric J; Wu, Benjamin; Zuk, Patricia (2018) MAPK signaling has stage-dependent osteogenic effects on human adipose-derived stem cells in vitro. Connect Tissue Res 59:129-146
Waters, Lynnea R; Ahsan, Fasih M; Wolf, Dane M et al. (2018) Initial B Cell Activation Induces Metabolic Reprogramming and Mitochondrial Remodeling. iScience 5:99-109
Van Dyk, Kathleen; Bower, Julienne E; Crespi, Catherine M et al. (2018) Cognitive function following breast cancer treatment and associations with concurrent symptoms. NPJ Breast Cancer 4:25
Robinett, Ryan A; Guan, Ning; Lux, Anja et al. (2018) Dissecting Fc?R Regulation through a Multivalent Binding Model. Cell Syst 7:41-48.e5
Chin, Chee Jia; Li, Suwen; Corselli, Mirko et al. (2018) Transcriptionally and Functionally Distinct Mesenchymal Subpopulations Are Generated from Human Pluripotent Stem Cells. Stem Cell Reports 10:436-446
Alban, Tyler J; Alvarado, Alvaro G; Sorensen, Mia D et al. (2018) Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis. JCI Insight 3:
Yang, Qing; Fung, Wing K; Li, Gang (2018) Sample size determination for jointly testing a cause-specific hazard and the all-cause hazard in the presence of competing risks. Stat Med 37:1389-1401
Seo, Jai Woong; Tavaré, Richard; Mahakian, Lisa M et al. (2018) CD8+ T-Cell Density Imaging with 64Cu-Labeled Cys-Diabody Informs Immunotherapy Protocols. Clin Cancer Res 24:4976-4987

Showing the most recent 10 out of 767 publications